SHANGHAI/SUZHOU--China’s vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA technology, but they face a ...
Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday. Shares of Moderna (MRNA), Pfizer (PFE) and Novavax (NVAX) all gained Friday, a broadly downbeat ...
Clinical Trials Arena on MSN7d
Everest Medicines begins dosing in mRNA cancer vaccine trialThe trial is jointly conducted at the Fudan University Shanghai Cancer Center and Peking University Cancer Hospital.
Adam Glanzman / Bloomberg via Getty Images Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday. Shares of Moderna (MRNA), Pfizer (PFE ...
Pharmaceutical giant Moderna Inc. saw its share prices grow by 5.34 percent on Friday to finish at $35.53 apiece following news that a new coronavirus with pandemic potential was discovered in China.
Dr. Vinod Balachandran says mRNA vaccines could stimulate the immune system to recognize and attack pancreatic cancer cells. An experimental approach to treating pancreatic cancer with the messenger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback